LUCKNOW: in Lucknow on
Sunday. A combination of natural extracts from plants, the drug is
based on Ayurveda and has no side effects. The drug is for management of
type-II diabetes mellitus.
The drug has been jointly
developed by two CSIR laboratories, National Botanical Research
Institute (NBRI) and Central Institute for Medicinal and Aromatic Plant
(CIMAP). It was launched on the 62nd annual day of the NBRI for
commercial manufacturing and marketing by M/s Aimil Pharamaceuticals Pvt
Ltd, New Delhi.
"The
drug has extracts from four plants mentioned in Ayurveda and that makes
it safe," said Dr AKS Rawat, senior principal scientist, NBRI. It has
been tested on animals and scientific study has found it safe and
effective, with clinical trials showing 67% success.
The
drug boosts immune system, works as antioxidant and checks free
radicals. Though there are other anti-diabetes herbal drugs in the
market, 'BGR-34' has been validated scientifically.
The
drug will help maintain normal blood glucose levels, reduce chances of
complications due to persistent high blood glucose levels and impart a
good quality life to patients with high blood sugar levels.
The
formulation was launched earlier by the Vice-President Hamid Ansari in
February last year at Vigyan Bhawan, New Delhi, but on Sunday, the
product was launched commercially.
"We will manufacture
it now and it will be available in market shortly, may be in the next 15
days," said V S Kapoor, marketing head of Aimil Pharmaceuticals for UP
and Delhi. It will be available in the form of tablets and may cost Rs
500 for 100 tablets.
